A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MECP2 | hg19_v2_chrX_-_153363125_153363182 | 0.96 | 2.3e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_20866424 Show fit | 3.38 |
ENST00000272224.3
|
growth differentiation factor 7 |
|
chr2_+_74212073 Show fit | 2.77 |
ENST00000441217.1
|
AC073046.25 |
|
chr3_-_126076264 Show fit | 1.75 |
ENST00000296233.3
|
Kruppel-like factor 15 |
|
chr4_+_1714548 Show fit | 1.63 |
ENST00000605571.1
|
RP11-572O17.1 |
|
chr17_+_59477233 Show fit | 1.55 |
ENST00000240328.3
|
T-box 2 |
|
chr20_-_19738569 Show fit | 1.50 |
ENST00000598007.1
|
Uncharacterized protein |
|
chr2_-_241500168 Show fit | 1.48 |
ENST00000443318.1
ENST00000411765.1 |
ankyrin repeat and MYND domain containing 1 |
|
chr11_+_45168182 Show fit | 1.34 |
ENST00000526442.1
|
PR domain containing 11 |
|
chr8_-_141645645 Show fit | 1.32 |
ENST00000519980.1
ENST00000220592.5 |
argonaute RISC catalytic component 2 |
|
chr20_-_61051026 Show fit | 1.26 |
ENST00000252997.2
|
GATA binding protein 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 4.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 3.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 3.6 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.6 | 3.5 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 3.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 3.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 3.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 2.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 2.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 9.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 5.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 4.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 4.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 4.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 3.2 | GO:0030496 | midbody(GO:0030496) |
0.0 | 3.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 3.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 3.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 3.1 | GO:0031526 | brush border membrane(GO:0031526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.5 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 7.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 4.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 4.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 3.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 3.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 3.2 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 3.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 3.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 2.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 4.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 4.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 4.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 4.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 4.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 3.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 3.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 3.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 3.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 5.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 5.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 4.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 4.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 4.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 3.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 3.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 3.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 3.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |